Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Boston Scientific Stent Shouldn’t Be Used Regularly, Study Says
Bloomberg
Friday, January 8, 2010 - 10:30am
tags:
stents, Boston Scientific
A Little Bit More On the Job Cuts at Merck & Pfizer
WSJ Online
Friday, January 8, 2010 - 10:23am
tags:
Merck, Pfizer, layoffs, Wyeth, Schering Plough
Icahn considering proxy battle at Genzyme: source
Yahoo/Reuters
Thursday, January 7, 2010 - 7:21pm
tags:
Genzyme, proxies, Carl Icahn
Teva sets goal to double revenue by 2015
Yahoo/AP
Thursday, January 7, 2010 - 7:21pm
tags:
Teva Pharmaceuticals, guidance
Pfizer Strides Farther Into Generics
Motley Fool
Thursday, January 7, 2010 - 7:19pm
tags:
generics, Pfizer, M&A, Strides Arcolab
States reach settlement with Abbott
Bizjournals.com
Thursday, January 7, 2010 - 7:18pm
tags:
Abbott Laboratories, settlements, antitrust, TriCor
Biotech Drugs to Watch In 2010
Minyanville
Thursday, January 7, 2010 - 11:14am
tags:
Arena Pharmaceuticals, Vivus, Orexigen, Novo Nordisk, Amylin, Eli Lilly, Biogen Idec, Acorda Therapeutics, Dendreon, MannKind
Vivus says mid-stage study shows its obesity drug candidate Qnexa reduced sleep apnea symptoms
Yahoo/AP
Thursday, January 7, 2010 - 11:10am
tags:
Vivus, Qnexa, sleep apnea
An Interview With Somaxon Pharma CEO Pascoe (Part I): Efficacy and Uncertainty of Sleep Drug Silenor
BNET Pharma
Thursday, January 7, 2010 - 11:08am
tags:
Silenor, Somaxon, insomnia
Analyst: China's vax industry poised for fast growth
Fierce Vaccines
Thursday, January 7, 2010 - 11:07am
tags:
China, vaccines
US FDA staff against wider approval of Forest drug
Reuters
Thursday, January 7, 2010 - 11:05am
tags:
Forest Labs, FDA, Bystolic
Cephalon's Nuvigil Under Pressure
Yahoo/Zacks.com
Thursday, January 7, 2010 - 11:04am
tags:
Cephalon, NUVIGIL, Watson Pharmaceuticals, Teva Pharmaceuticals
Diet Drug Maker Glaxo to Pay for a Film on Eating
NY Times, NY
Thursday, January 7, 2010 - 11:03am
tags:
GSK, Alli, diet drugs
[video]Biotech 2010 Winners
Yahoo/TheStreet.com
Thursday, January 7, 2010 - 11:01am
tags:
biotech
CEO James Mullen's Departure from Biogen Idec: The Good, the Bad and the Ugly
BNET Pharma
Thursday, January 7, 2010 - 10:18am
tags:
Biogen Idec, James Mullen
Novartis to Buy Aclon: Will the Gurus Sell?
Seeking Alpha
Thursday, January 7, 2010 - 10:01am
tags:
Novartis, Alcon, M&A
Pfizer enters melanoma partnership with Debiopharm
Yahoo/AP
Thursday, January 7, 2010 - 10:00am
tags:
Pfizer, Debiopharm, melanoma, partnerships
ZymoGenetics selling 12M shares of stock to raise $80M
Bizjournals.com
Thursday, January 7, 2010 - 10:00am
tags:
stock offering, ZymoGenetics
Biogen discloses more PML cases
Bizjournals.com
Thursday, January 7, 2010 - 9:57am
tags:
PML, Biogen Idec, Tysabri
Teva, AstraZeneca end dispute on Prilosec, Nexium
Marketwatch
Thursday, January 7, 2010 - 9:56am
tags:
Prilosec, Nexium, generics, Teva Pharmaceuticals, AstraZeneca

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.